Hesham ElAbd
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hesham ElAbd has a total of 239 co-authors. Here are the top co-authors by number of shared publications:
- Andre Franke
Institute of Clinical Molecular Biology, Kiel University and University Hospital Schleswig-Holstein, Kiel, Germany
15 shared publications - Aya K. H. Mahdy
Institute of Clinical Molecular Biology, Kiel University and University Hospital Schleswig-Holstein (UKSH) , Kiel, 24105
9 shared publications Andre Franke
7 shared publicationsBryan Howie
Adaptive Biotechnologies, Seattle, USA
4 shared publications- David Ellinghaus
Institute of Clinical Molecular Biology, Kiel University and University Medical Center Schleswig-Holstein, Kiel, Germany
4 shared publications - Frauke Degenhardt
Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel , Kiel , Germany
4 shared publications
Latest Publications
- 2 November 2026
- Published by Springer Nature in Nature Reviews Genetics
- p. 1-22
Sequencing and analysis of the human adaptive immune receptor repertoire
Adaptive immune cell populations (T cells and B cells) retain a molecular record of immune exposures, including infection and vaccination, in their specific antigen receptor repertoires. These receptor repertoires arise through V(D)J recombination, which assembles distinct combinations of germline-encoded V, D and J gene segments and introduces extensive junctional diversification to generate highly diverse antigen receptors that are subsequently shaped by developmental selection and antigen exposure. Recent advances in high-throughput sequencing enable adaptive immune receptor repertoires to be profiled at scale, across large cohorts and with increasing depth within individual samples. As a result, receptor repertoire profiling is emerging as a powerful approach for monitoring disease course and treatment responses in cancer, quantifying immune responses to infection and vaccination, and dissecting the immunological basis of inflammatory disease. In this Review, we discuss how human T cell and B cell receptor repertoires are formed, how inherited genetic variation shapes their architecture and how experimental and computational advances are enabling repertoire data to be translated into biological insight, clinical utility and repertoire-guided therapeutic opportunities.
- 2 November 2026
- Published by Springer Nature in Nature Reviews Genetics
- p. 1-22
Sequencing and analysis of the human adaptive immune receptor repertoire
Adaptive immune cell populations (T cells and B cells) retain a molecular record of immune exposures, including infection and vaccination, in their specific antigen receptor repertoires. These receptor repertoires arise through V(D)J recombination, which assembles distinct combinations of germline-encoded V, D and J gene segments and introduces extensive junctional diversification to generate highly diverse antigen receptors that are subsequently shaped by developmental selection and antigen exposure. Recent advances in high-throughput sequencing enable adaptive immune receptor repertoires to be profiled at scale, across large cohorts and with increasing depth within individual samples. As a result, receptor repertoire profiling is emerging as a powerful approach for monitoring disease course and treatment responses in cancer, quantifying immune responses to infection and vaccination, and dissecting the immunological basis of inflammatory disease. In this Review, we discuss how human T cell and B cell receptor repertoires are formed, how inherited genetic variation shapes their architecture and how experimental and computational advances are enabling repertoire data to be translated into biological insight, clinical utility and repertoire-guided therapeutic opportunities.
- Open Access
- 27 October 2026
- Published by Elsevier in Cell Reports
- Vol. 45 (11)
PhIP-Seq reveals geography- and disease-associated human herpesvirus antibody repertoires and distinct EBV response modules
- 27 October 2026
- Published by Elsevier in Cell Reports
- Vol. 45 (11)
Open AccessPhIP-Seq reveals geography- and disease-associated human herpesvirus antibody repertoires and distinct EBV response modules
- Open Access
- 4 May 2026
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
Calling for Diversity: Improving Transfusion Safety Through High-Throughput Blood Group Microarray Genotyping
Blood transfusions, conducted between donors compatible in their red blood cell (RBC) antigens, play a life-saving role in transfusion medicine. Genetic differences at blood group loci between ethnicities result in diversity and altered frequency of RBC antigens that need to be considered in blood transfusions. Consequently, comprehensive and accurate blood group antigen typing is especially relevant for interethnic blood transfusions and for minorities underrepresented in the donor population. Blood group microarray genotyping is a cost-efficient and scalable method for comprehensive blood group typing. Previously, however, microarray typing was challenging for the clinically important blood group systems Rh and MNS, as these feature highly paralogous genomic loci, which lead to mixed signals. Here, we present an approach for accurately typing blood group systems, including Rh and MNS variations. We benchmarked this approach in an ethnically diverse cohort. We tested its performance using gold-standard, diagnostic-grade matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) data from 1052 samples, including 334 Centre d’Etude du Polymorphisme Humain (CEPH)-diversity samples. Overall, we obtained a 99.95% benchmarking concordance and a 99.65% call rate. In summary, we provide a highly accurate and cost-efficient high-throughput genotyping method for comprehensive blood group analysis that is also suitable for ethnically diverse sample sets (https://github.com/ikmb/BloodTypingArray).
- 4 May 2026
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
Open AccessCalling for Diversity: Improving Transfusion Safety Through High-Throughput Blood Group Microarray Genotyping
Blood transfusions, conducted between donors compatible in their red blood cell (RBC) antigens, play a life-saving role in transfusion medicine. Genetic differences at blood group loci between ethnicities result in diversity and altered frequency of RBC antigens that need to be considered in blood transfusions. Consequently, comprehensive and accurate blood group antigen typing is especially relevant for interethnic blood transfusions and for minorities underrepresented in the donor population. Blood group microarray genotyping is a cost-efficient and scalable method for comprehensive blood group typing. Previously, however, microarray typing was challenging for the clinically important blood group systems Rh and MNS, as these feature highly paralogous genomic loci, which lead to mixed signals. Here, we present an approach for accurately typing blood group systems, including Rh and MNS variations. We benchmarked this approach in an ethnically diverse cohort. We tested its performance using gold-standard, diagnostic-grade matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) data from 1052 samples, including 334 Centre d’Etude du Polymorphisme Humain (CEPH)-diversity samples. Overall, we obtained a 99.95% benchmarking concordance and a 99.65% call rate. In summary, we provide a highly accurate and cost-efficient high-throughput genotyping method for comprehensive blood group analysis that is also suitable for ethnically diverse sample sets (https://github.com/ikmb/BloodTypingArray).
- Open Access
- 17 April 2026
- Published by Elsevier in JHEP Reports
- Vol. 8 (9) , 101857
Intrahepatic T cell analysis reveals Th17 and MAIT17 enrichment in primary sclerosing cholangitis
- 17 April 2026
- Published by Elsevier in JHEP Reports
- Vol. 8 (9) , 101857
Open AccessIntrahepatic T cell analysis reveals Th17 and MAIT17 enrichment in primary sclerosing cholangitis
- Open Access
- 8 April 2026
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 20 (4)
Mapping adaptive immune responses toward fungal antigens in inflammatory bowel disease using T cell repertoire sequencing and phage-immunoprecipitation sequencing
Background and Aims: Immune reactivity to the gut mycobiome has been implicated in inflammatory bowel disease (IBD), particularly Crohn’s disease (CD), but the systemic adaptive immune repertoire targeting the gut mycobiome remains incompletely defined. We aimed to map systemic T cell and antibody responses to fungal antigens in IBD. Methods: We quantified expansion of fungal-specific T cell receptor β (TRB) clonotypes in the SPARC IBD cohort (CD, n = 1890; ulcerative colitis [UC], n = 914). In participants with paired data (n = 637), we analyzed the gut mycobiome by ITS2 sequencing and linked prevalent amplicon sequence variants (ASVs) to TRB clonotypes using a co-occurrence framework. For humoral immune profiling, we built a Saccharomyces cerevisiae-focused PhIP-Seq library and screened sera from CD (n = 100) and healthy controls (n = 60), including anti-S. cerevisiae antibody+ (ASCA+) and ASCA− individuals. Results: Fungal-specific TRB clonotypes showed greater expansion in CD than UC, including increased responses toward S. cerevisiae and enrichment in more aggressive CD phenotypes. Co-occurrence analysis identified a limited number of TRB–mycobiota associations, consistent with the largely private nature of the gut mycobiome at the ASV level. Antibody reactivity to S. cerevisiae peptides was low relative to common viral and bacterial antigen classes, and no single S. cerevisiae peptide was associated with anti-S. cerevisiae antibody serostatus. Conclusions: CD is associated with expansion of fungal-specific T cell clonotypes, but S. cerevisiae peptide-based PhIP-Seq reveals limited shared IgG reactivity. Broader antigen libraries and complementary assays capturing glycosylated and virulence-associated fungal epitopes will be needed to comprehensively define antifungal humoral immunity in IBD.
- 8 April 2026
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 20 (4)
Open AccessMapping adaptive immune responses toward fungal antigens in inflammatory bowel disease using T cell repertoire sequencing and phage-immunoprecipitation sequencing
Background and Aims: Immune reactivity to the gut mycobiome has been implicated in inflammatory bowel disease (IBD), particularly Crohn’s disease (CD), but the systemic adaptive immune repertoire targeting the gut mycobiome remains incompletely defined. We aimed to map systemic T cell and antibody responses to fungal antigens in IBD. Methods: We quantified expansion of fungal-specific T cell receptor β (TRB) clonotypes in the SPARC IBD cohort (CD, n = 1890; ulcerative colitis [UC], n = 914). In participants with paired data (n = 637), we analyzed the gut mycobiome by ITS2 sequencing and linked prevalent amplicon sequence variants (ASVs) to TRB clonotypes using a co-occurrence framework. For humoral immune profiling, we built a Saccharomyces cerevisiae-focused PhIP-Seq library and screened sera from CD (n = 100) and healthy controls (n = 60), including anti-S. cerevisiae antibody+ (ASCA+) and ASCA− individuals. Results: Fungal-specific TRB clonotypes showed greater expansion in CD than UC, including increased responses toward S. cerevisiae and enrichment in more aggressive CD phenotypes. Co-occurrence analysis identified a limited number of TRB–mycobiota associations, consistent with the largely private nature of the gut mycobiome at the ASV level. Antibody reactivity to S. cerevisiae peptides was low relative to common viral and bacterial antigen classes, and no single S. cerevisiae peptide was associated with anti-S. cerevisiae antibody serostatus. Conclusions: CD is associated with expansion of fungal-specific T cell clonotypes, but S. cerevisiae peptide-based PhIP-Seq reveals limited shared IgG reactivity. Broader antigen libraries and complementary assays capturing glycosylated and virulence-associated fungal epitopes will be needed to comprehensively define antifungal humoral immunity in IBD.
- Open Access
- 13 January 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1) , 50
T cell receptor clonotypes predict human leukocyte antigen allele carriage and antigen exposure history
Conventional T cells recognize peptides presented by the human leukocyte antigen (HLA) proteins through their T cell receptors (TCRs). Given that thousands of HLA proteins have been discovered, each presenting thousands of different peptides, decoding the cognate HLA protein of a TCR experimentally is a challenging task. To address this problem, we combined statistical learning methods with a unique dataset of paired T cell repertoires and HLA allotypes for 6,794 individuals. This enabled us to discover 34,206 T cell receptor alpha (TRA) and 891,564 beta (TRB) clonotypes that were associated with 175 unique HLA alleles. The identified clonotypes target prevalent infections, e.g . influenza, cytomegalovirus and Epstein-Barr virus. Utilizing these clonotypes, we develop statistical models that impute the carriership of common HLA alleles from the TRA- or the TRB- repertoire. In conclusion, the identified allele-associated clonotypes encode the HLA fingerprints and the antigenic exposure history of individuals and populations.
- 13 January 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1) , 50
Open AccessT cell receptor clonotypes predict human leukocyte antigen allele carriage and antigen exposure history
Conventional T cells recognize peptides presented by the human leukocyte antigen (HLA) proteins through their T cell receptors (TCRs). Given that thousands of HLA proteins have been discovered, each presenting thousands of different peptides, decoding the cognate HLA protein of a TCR experimentally is a challenging task. To address this problem, we combined statistical learning methods with a unique dataset of paired T cell repertoires and HLA allotypes for 6,794 individuals. This enabled us to discover 34,206 T cell receptor alpha (TRA) and 891,564 beta (TRB) clonotypes that were associated with 175 unique HLA alleles. The identified clonotypes target prevalent infections, e.g . influenza, cytomegalovirus and Epstein-Barr virus. Utilizing these clonotypes, we develop statistical models that impute the carriership of common HLA alleles from the TRA- or the TRB- repertoire. In conclusion, the identified allele-associated clonotypes encode the HLA fingerprints and the antigenic exposure history of individuals and populations.
- Open Access
The dynamic role of HLA proteins on compositional alterations of T-cell repertoires in inflammatory bowel disease
Background: Inflammatory bowel disease (IBD), which is characterised by genetic predispositions and dysregulated immune responses, is rapidly emerging as a global health challenge. Genetic variations in the human leukocyte antigen (HLA) region are strongly associated with IBD; nonetheless, the functional consequences of this variation on the composition of T-cell receptors remain poorly understood. Methods: We conducted comprehensive CDR3-QTL mapping using T-cell receptor beta (TRB) repertoires paired with HLA allotypes from 1,973 individuals, including 1,201 individuals with IBD and 772 healthy controls (HCs), to explore the role of the HLA allelic variants on TRB composition. Using network analyses, we defined key CDR3 motifs of public clones that were linked to risk HLA alleles for chronic inflammatory diseases. Results: We identified novel sites within both HLA class I and class II proteins that were strongly linked to TRB amino acid composition – cdr3 QTLs, in both HCs and individuals with IBD. Those sites in HLA-DRB1 and HLA-DQ had stronger effects on CDR3 composition than did the disease in the IBD cohort. In HCs, but not in UC or CD, the strongest HLA signals that affected expanded clones, overlapped with primary CD risk loci from GWAS, e.g. , DRB1 site 70 and DQA1 site 25. The strongest CD-specific effects on TRB composition were found in HLA-B, especially at sites that modulate viral responses ( e.g. , HLA-B sites 9, 67). Finally, the main risk HLA alleles for chronic inflammatory diseases clustered together based on the physicochemical properties of residues mapped to cdr3 QTLs, suggesting that risk alleles might exert similar effects on the TRB repertoire. Conclusion: Structurally, the main cdr3 QTLs in both HLA class I/II are located in peptide-binding sites or sites contacting TCRs, highlighting their direct and antigen-mediated influences on TRB repertoires. Our findings suggest that cdr3 QTLs in HLA class I exert IBD-specific effects on the TRB composition, influencing the dysregulated T cell responses implicated in IBD pathogenesis, possibly on the earlier stages of T cell development. While HLA class II cdr3 QTLs show universal effects and strong associations with T-cell receptors, irrespective of disease.
Open AccessThe dynamic role of HLA proteins on compositional alterations of T-cell repertoires in inflammatory bowel disease
Background: Inflammatory bowel disease (IBD), which is characterised by genetic predispositions and dysregulated immune responses, is rapidly emerging as a global health challenge. Genetic variations in the human leukocyte antigen (HLA) region are strongly associated with IBD; nonetheless, the functional consequences of this variation on the composition of T-cell receptors remain poorly understood. Methods: We conducted comprehensive CDR3-QTL mapping using T-cell receptor beta (TRB) repertoires paired with HLA allotypes from 1,973 individuals, including 1,201 individuals with IBD and 772 healthy controls (HCs), to explore the role of the HLA allelic variants on TRB composition. Using network analyses, we defined key CDR3 motifs of public clones that were linked to risk HLA alleles for chronic inflammatory diseases. Results: We identified novel sites within both HLA class I and class II proteins that were strongly linked to TRB amino acid composition – cdr3 QTLs, in both HCs and individuals with IBD. Those sites in HLA-DRB1 and HLA-DQ had stronger effects on CDR3 composition than did the disease in the IBD cohort. In HCs, but not in UC or CD, the strongest HLA signals that affected expanded clones, overlapped with primary CD risk loci from GWAS, e.g. , DRB1 site 70 and DQA1 site 25. The strongest CD-specific effects on TRB composition were found in HLA-B, especially at sites that modulate viral responses ( e.g. , HLA-B sites 9, 67). Finally, the main risk HLA alleles for chronic inflammatory diseases clustered together based on the physicochemical properties of residues mapped to cdr3 QTLs, suggesting that risk alleles might exert similar effects on the TRB repertoire. Conclusion: Structurally, the main cdr3 QTLs in both HLA class I/II are located in peptide-binding sites or sites contacting TCRs, highlighting their direct and antigen-mediated influences on TRB repertoires. Our findings suggest that cdr3 QTLs in HLA class I exert IBD-specific effects on the TRB composition, influencing the dysregulated T cell responses implicated in IBD pathogenesis, possibly on the earlier stages of T cell development. While HLA class II cdr3 QTLs show universal effects and strong associations with T-cell receptors, irrespective of disease.
- Open Access
High throughput profiling of the B cell repertoire identifies systematic changes in the repertoire of individuals with Crohn’s disease
The B cell repertoire contains the recombined DNA sequences that encodes the entire antibody repertoire of an individual. The repertoire is made from three antigenic binding chains, namely the immunoglobulin heavy chain (IGH) and two immunoglobulin light chains, κ (IGK) and λ (IGL). Compared to the T cell repertoire, the B cell repertoire is understudied in inflammatory bowel diseases (IBD) even though different antibodies such as ASCA and ANCA have been shown to be elevated in individuals with IBD. Furthermore, most IBD B cell repertoire studies have profiled the repertoire of treated individuals, thus capturing the combined effect of treatment and disease on the repertoire. To address this limitation, we profiled the repertoire of 24 treatment-naive individuals with CD with matching 24 symptomatic controls. The repertoire of individuals with CD showed a significant reduction in diversity and an increase in clonality, suggesting an antigen-driven expansion of clonotypes that might be driving the disease. Furthermore, we observed a significant reduction in the expansion of IgM and IgD and an expansion of IgA2 and IgG2 clonotypes in individuals with CD relative to controls. Lastly, we observed a reduction in the somatic hypermutation rate in the IGH J gene, particularly in IgM and IgA1 clonotypes, among individuals with CD relative to controls. Thus, despite the small sample size, we identified multiple alterations in the B cell repertoire of individuals with CD, highlighting the potential of the B cell repertoire in identifying antigenic exposures implicated in the diseases, demanding now larger international studies ideally including also treatment-naive and pre-clinical cases.
Open AccessHigh throughput profiling of the B cell repertoire identifies systematic changes in the repertoire of individuals with Crohn’s disease
The B cell repertoire contains the recombined DNA sequences that encodes the entire antibody repertoire of an individual. The repertoire is made from three antigenic binding chains, namely the immunoglobulin heavy chain (IGH) and two immunoglobulin light chains, κ (IGK) and λ (IGL). Compared to the T cell repertoire, the B cell repertoire is understudied in inflammatory bowel diseases (IBD) even though different antibodies such as ASCA and ANCA have been shown to be elevated in individuals with IBD. Furthermore, most IBD B cell repertoire studies have profiled the repertoire of treated individuals, thus capturing the combined effect of treatment and disease on the repertoire. To address this limitation, we profiled the repertoire of 24 treatment-naive individuals with CD with matching 24 symptomatic controls. The repertoire of individuals with CD showed a significant reduction in diversity and an increase in clonality, suggesting an antigen-driven expansion of clonotypes that might be driving the disease. Furthermore, we observed a significant reduction in the expansion of IgM and IgD and an expansion of IgA2 and IgG2 clonotypes in individuals with CD relative to controls. Lastly, we observed a reduction in the somatic hypermutation rate in the IGH J gene, particularly in IgM and IgA1 clonotypes, among individuals with CD relative to controls. Thus, despite the small sample size, we identified multiple alterations in the B cell repertoire of individuals with CD, highlighting the potential of the B cell repertoire in identifying antigenic exposures implicated in the diseases, demanding now larger international studies ideally including also treatment-naive and pre-clinical cases.
- Open Access
Quantifying The Impact of Bulk TCR-Seq Methodological Choices on The Profiled T Cell Repertoire
Bulk T cell repertoire profiling using sequencing (TCR-Seq) is a powerful method to investigate T cell responses to natural infections, vaccines, cancers, and autoimmune diseases. This assay can be conducted using various techniques, such as multiplex PCR or 5’-RACE. However, each methods introduces systematic biases that can result in different pictures of the underlying T cell repertoire. Furthermore, the impact of technical variables on the accuracy of these methods remains understudied. Thus, in this study, we systematically characterized different multiplex PCR-based protocols, focusing on the quality and quantity of the utilized RNA/DNA, extraction methods, amplification programs, variations between production batches, and technical handling of samples. Our findings highlight the important role of RNA/DNA quality in shaping the profiling results of T cell repertoires. Whereas low RNA/DNA quantities can be partially compensated for by increasing the number of PCR cycles, this is partially not possible with lower quality. In conclusion, our results highlight the influence of different technical choices on the biological conclusions drawn from TCR-Seq data and provide practical guidelines to finetune these variables to ensure consistent and reliable results under diverse experimental constraints.
Open AccessQuantifying The Impact of Bulk TCR-Seq Methodological Choices on The Profiled T Cell Repertoire
Bulk T cell repertoire profiling using sequencing (TCR-Seq) is a powerful method to investigate T cell responses to natural infections, vaccines, cancers, and autoimmune diseases. This assay can be conducted using various techniques, such as multiplex PCR or 5’-RACE. However, each methods introduces systematic biases that can result in different pictures of the underlying T cell repertoire. Furthermore, the impact of technical variables on the accuracy of these methods remains understudied. Thus, in this study, we systematically characterized different multiplex PCR-based protocols, focusing on the quality and quantity of the utilized RNA/DNA, extraction methods, amplification programs, variations between production batches, and technical handling of samples. Our findings highlight the important role of RNA/DNA quality in shaping the profiling results of T cell repertoires. Whereas low RNA/DNA quantities can be partially compensated for by increasing the number of PCR cycles, this is partially not possible with lower quality. In conclusion, our results highlight the influence of different technical choices on the biological conclusions drawn from TCR-Seq data and provide practical guidelines to finetune these variables to ensure consistent and reliable results under diverse experimental constraints.
- Open Access
Analyzing the T cell receptor repertoire of 2,804 individuals with inflammatory bowel disease identifies public T cell responses involved in the pathogenesis
Whereas altered immune processes have been identified in individuals with inflammatory bowel disease (IBD), potentially causative antigens remain to be identified. By interrogating the immune repertoire of individuals with IBD, an identification of common antigenic exposures associated with the disease can be obtained. We analyzed the T cell receptor beta (TRB) chain repertoire of 1,890 individuals with Crohn’s disease (CD) and 914 individuals with ulcerative colitis (UC), enabling the identification of 327 TRB clonotypes associated with CD and 130 with UC. We validated the expansion of these clonotypes in a cohort of treatment-naïve individuals with either CD, UC or symptomatic control (n=855). These disease-associated clonotypes were restricted to disease-associated risk HLA alleles and their expansion correlated with disease-severity but not with surgery or treatment trajectory. In conclusion, we identified and validated TRB clonotypes that are associated with either CD or UC, these clonotypes are a novel therapeutic target in IBD.
Open AccessAnalyzing the T cell receptor repertoire of 2,804 individuals with inflammatory bowel disease identifies public T cell responses involved in the pathogenesis
Whereas altered immune processes have been identified in individuals with inflammatory bowel disease (IBD), potentially causative antigens remain to be identified. By interrogating the immune repertoire of individuals with IBD, an identification of common antigenic exposures associated with the disease can be obtained. We analyzed the T cell receptor beta (TRB) chain repertoire of 1,890 individuals with Crohn’s disease (CD) and 914 individuals with ulcerative colitis (UC), enabling the identification of 327 TRB clonotypes associated with CD and 130 with UC. We validated the expansion of these clonotypes in a cohort of treatment-naïve individuals with either CD, UC or symptomatic control (n=855). These disease-associated clonotypes were restricted to disease-associated risk HLA alleles and their expansion correlated with disease-severity but not with surgery or treatment trajectory. In conclusion, we identified and validated TRB clonotypes that are associated with either CD or UC, these clonotypes are a novel therapeutic target in IBD.